NS Wind Down Co (NSTGQ) Osake Kurssi
NS Wind Down Co Kurssi
Viimeisten 14 vuoden aikana NS Wind Down Con liikevaihto kasvoi 36,7 % vuodessa ja ylsi 127,26 M USD:een. NS Wind Down Con nettomarginaali −125,4 % on laskenut verrattuna −72,5 %:iin muutama vuosi sitten.
NS Wind Down Co osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
NS Wind Down Co liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset NS Wind Down Co -osakkeesta
NanoString Technologies Inc. is a leading provider of life science tools for translational research and molecular diagnostics. The business model of NanoString Technologies is focused on developing and commercializing proprietary technologies, including the nCounter Analysis System, which enables researchers to profile gene expression and gain insights into a wide range of biological systems and diseases. By offering high-quality, scalable, and easy-to-use solutions, NanoString Technologies aims to empower researchers in various fields, including drug development, biomarker discovery, and cancer research. With a strong emphasis on innovation and customer satisfaction, NanoString Technologies Inc. strives to deliver cutting-edge solutions that drive advancements in molecular biology and enable breakthrough discoveries.
NanoString Technologies Inc is primarily active in the field of life sciences and healthcare industries.
The main competitors of NanoString Technologies Inc in the market are Illumina Inc, Thermo Fisher Scientific Inc, and QIAGEN N.V.
NanoString Technologies Inc. is a leading provider of life science tools for translational research and molecular diagnostics. Founded in 2003, the company is headquartered in Seattle, Washington. NanoString's innovative nCounter Analysis System enables researchers to perform high-resolution analysis of gene expression and DNA/RNA analysis, offering a powerful platform for understanding disease pathways, drug responses, and biomarker discovery. With a focus on precision oncology and immunology, NanoString Technologies Inc. has established collaborations with various academic institutions and pharmaceutical companies. The company has consistently expanded its product portfolio and continues to play a significant role in advancing molecular research and personalized medicine. NanoString Technologies Inc. is committed to revolutionizing the field of genomics through its cutting-edge technology and collaborations.
NanoString Technologies Inc has achieved several significant milestones. Firstly, the company developed and commercialized the nCounter Analysis System, a unique platform for molecular profiling. This innovative technology has empowered researchers to explore biological systems with high precision. Additionally, NanoString Technologies Inc launched various genomic panels, including the Prosigna Breast Cancer Assay, which enables healthcare professionals to make informed decisions regarding breast cancer management. The company has also forged strategic partnerships with leading institutions and pharmaceutical companies to advance precision medicine. NanoString Technologies Inc continues to make strides in the field of molecular diagnostics and remains dedicated to driving advancements in personalized medicine.
NanoString Technologies Inc is primarily present in various countries and regions worldwide. The company has a global presence, with notable operations in the United States, Europe, Asia-Pacific, and Latin America. NanoString Technologies Inc has established a strong network of customers, collaborators, and distributors across these regions, enabling it to cater to a broad customer base. By continuously expanding its reach and forging strategic partnerships, NanoString Technologies Inc aims to deliver its innovative solutions for genetic analysis and provide value to researchers, clinicians, and diagnostic laboratories in different parts of the world.
NanoString Technologies Inc represents a commitment to innovation and advancement in the field of genomics. The company aims to provide solutions that enable researchers to deeply understand the intricacies of biology, thereby helping clinicians make more informed treatment decisions. NanoString believes in empowering its customers with cutting-edge technology, such as its nCounter Analysis System, which enables highly multiplexed, digital gene expression analysis. The company's corporate philosophy revolves around collaboration, integrity, and a passion for making a lasting impact on patient care and outcomes. NanoString Technologies Inc understands the significance of genomics in transforming healthcare and is dedicated to driving advancements in this rapidly evolving field.
15 analyytikkoa arvioi tällä hetkellä NS Wind Down Co-osaketta: 10 suosittaa ostoa, 5 pitoa ja 0 myyntiä.
Nykyisellä valuuttakurssilla NS Wind Down Co-osake noteerataan hintaan 0,06 EUR (0,07 USD).
NS Wind Down Co-osake (NSTGQ) on listattuna 5 pörssissä, muun muassa: NASDAQ (NSTG), SIX (Zürich) (0F1.SW), Frankfurt (0F1.F), München (0F1.MU), Düsseldorf (0F1.DU).
NanoString Technologies Inc is a biotechnology company focused on developing innovative products for genomics. The company's business model is based on manufacturing and selling devices, consumables, and services for genomic research. They offer the nCounter system for RNA and DNA analysis, specialized panels for specific applications, and diagnostic services. NanoString also has partnerships with other biotechnology companies to expand its product offerings. The company has a global presence with offices in North America, Europe, and Asia. NanoString's focus on research and development allows them to provide tailored solutions for customers and strive towards wider applications in diagnostics and precision medicine. Overall, NanoString is a leading player in genomics and is expected to continue diversifying and expanding its product portfolio to meet customer demands.
Liikevaihtoa ei voida laskea NS Wind Down Co:lle tällä hetkellä.
Voittoa ei voida laskea NS Wind Down Co:lle tällä hetkellä.
P/E-suhdetta ei voida laskea NS Wind Down Co:lle tällä hetkellä.
P/S-suhdetta ei voida laskea NS Wind Down Co:lle tällä hetkellä.
NS Wind Down Co:n Eulpool-laatuscore on 3/10.
NS Wind Down Co:n ISIN on US63009R1095. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
NS Wind Down Co:n WKN on A1W1X2. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
NS Wind Down Co:n ticker on NSTGQ. Tämä pörssinoteeraus käytetään NS Wind Down Co-osakkeiden kauppaan pörssissä.
NS Wind Down Co osake
NS Wind Down Co vertaisryhmä
NS Wind Down Co Ticker
NS Wind Down Co FIGI
Kaikki tunnusluvut ja syvällinen analyysi NS Wind Down Co:sta
Meidän osakeanalyysimme NS Wind Down Co-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut NS Wind Down Co:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: